FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024247458> ?p ?o ?g. }

• W2024247458 abstract "This prospective multicenter study examined whether elevated fecal calprotec tin (FC) concentrations after stopping TNFα-blocking therapy can predict clinical or endoscopic relapse. In addition, we evaluated the impact of histological remission on the relapse risk. We enrolled inflammatory bowel disease (IBD) patients who were in clinical, endoscopic, and FC-based (< 100 μg/g) remission after a minimum 11 months of TNFα-blocking therapy. The patients were followed-up for 12 months after the discontinuation of TNFα-blocking therapy. FC was collected monthly for the first 6 months and thereafter every second month. Ileocolonoscopy was performed at inclusion, at 4 months, at the study end, and at the time of clinical relapse. Of 52 enrolled patients, 49 (16 Crohn's disease, 33 ulcerative colitis/IBD unclassified) provided the stool samples requested and comprised the study group. During the follow-up, 15/49 (31%) relapsed, whereas 34 (69%) remained in remission. Patients relapsing showed constantly elevated FC levels for a median of 94 (13–317) days before the relapse. Significant increase in median FC levels was seen 2 (p = 0.0014), 4 (p = 0.0056), and 6 (p = 0.0029) months before endoscopic relapse. Constantly normal FC concentrations during the follow-up were highly predictive for clinical and endoscopic remission. Normal FC concentrations in patients with remission were associated with histological remission. FC seems to increase and remain elevated before clinical or endoscopic relapse, suggesting that it can be used as a surrogate marker for predicting and identifying patients requiring close follow-up in clinical practice." @default.
• W2024247458 created "2016-06-24" @default.
• W2024247458 creator A5001187106 @default.
• W2024247458 creator A5001951186 @default.
• W2024247458 creator A5004254252 @default.
• W2024247458 creator A5004472734 @default.
• W2024247458 creator A5005213853 @default.
• W2024247458 creator A5006863457 @default.
• W2024247458 creator A5008547959 @default.
• W2024247458 creator A5016571626 @default.
• W2024247458 creator A5023934960 @default.
• W2024247458 creator A5025667807 @default.
• W2024247458 creator A5026826471 @default.
• W2024247458 creator A5034887113 @default.
• W2024247458 creator A5036068482 @default.
• W2024247458 creator A5044664551 @default.
• W2024247458 creator A5044719309 @default.
• W2024247458 creator A5049950699 @default.
• W2024247458 creator A5065139294 @default.
• W2024247458 creator A5080445150 @default.
• W2024247458 date "2014-07-01" @default.
• W2024247458 modified "2023-10-17" @default.
• W2024247458 title "Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?" @default.
• W2024247458 cites W1568563504 @default.
• W2024247458 cites W1987064800 @default.
• W2024247458 cites W1990311132 @default.
• W2024247458 cites W1991966978 @default.
• W2024247458 cites W1997208427 @default.
• W2024247458 cites W1997702183 @default.
• W2024247458 cites W2009028255 @default.
• W2024247458 cites W2024959214 @default.
• W2024247458 cites W2025549389 @default.
• W2024247458 cites W2028006265 @default.
• W2024247458 cites W2031860350 @default.
• W2024247458 cites W2032206624 @default.
• W2024247458 cites W2036503241 @default.
• W2024247458 cites W2049194517 @default.
• W2024247458 cites W2052496052 @default.
• W2024247458 cites W2052776464 @default.
• W2024247458 cites W2054378007 @default.
• W2024247458 cites W2056629400 @default.
• W2024247458 cites W2060635758 @default.
• W2024247458 cites W2061837689 @default.
• W2024247458 cites W2071662837 @default.
• W2024247458 cites W2077570588 @default.
• W2024247458 cites W2088874765 @default.
• W2024247458 cites W2091592849 @default.
• W2024247458 cites W2096308931 @default.
• W2024247458 cites W2098295867 @default.
• W2024247458 cites W2109518441 @default.
• W2024247458 cites W2125677376 @default.
• W2024247458 cites W2157657209 @default.
• W2024247458 cites W2158926558 @default.
• W2024247458 cites W2160240762 @default.
• W2024247458 cites W2160889746 @default.
• W2024247458 cites W2321205867 @default.
• W2024247458 cites W4237097915 @default.
• W2024247458 cites W4248766974 @default.
• W2024247458 doi "https://doi.org/10.1016/j.crohns.2014.06.012" @default.
• W2024247458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25052347" @default.
• W2024247458 hasPublicationYear "2014" @default.
• W2024247458 type Work @default.
• W2024247458 sameAs 2024247458 @default.
• W2024247458 citedByCount "56" @default.
• W2024247458 countsByYear W20242474582015 @default.
• W2024247458 countsByYear W20242474582016 @default.
• W2024247458 countsByYear W20242474582017 @default.
• W2024247458 countsByYear W20242474582018 @default.
• W2024247458 countsByYear W20242474582019 @default.
• W2024247458 countsByYear W20242474582020 @default.
• W2024247458 countsByYear W20242474582021 @default.
• W2024247458 countsByYear W20242474582022 @default.
• W2024247458 countsByYear W20242474582023 @default.
• W2024247458 crossrefType "journal-article" @default.
• W2024247458 hasAuthorship W2024247458A5001187106 @default.
• W2024247458 hasAuthorship W2024247458A5001951186 @default.
• W2024247458 hasAuthorship W2024247458A5004254252 @default.
• W2024247458 hasAuthorship W2024247458A5004472734 @default.
• W2024247458 hasAuthorship W2024247458A5005213853 @default.
• W2024247458 hasAuthorship W2024247458A5006863457 @default.
• W2024247458 hasAuthorship W2024247458A5008547959 @default.
• W2024247458 hasAuthorship W2024247458A5016571626 @default.
• W2024247458 hasAuthorship W2024247458A5023934960 @default.
• W2024247458 hasAuthorship W2024247458A5025667807 @default.
• W2024247458 hasAuthorship W2024247458A5026826471 @default.
• W2024247458 hasAuthorship W2024247458A5034887113 @default.
• W2024247458 hasAuthorship W2024247458A5036068482 @default.
• W2024247458 hasAuthorship W2024247458A5044664551 @default.
• W2024247458 hasAuthorship W2024247458A5044719309 @default.
• W2024247458 hasAuthorship W2024247458A5049950699 @default.
• W2024247458 hasAuthorship W2024247458A5065139294 @default.
• W2024247458 hasAuthorship W2024247458A5080445150 @default.
• W2024247458 hasBestOaLocation W20242474581 @default.
• W2024247458 hasConcept C126322002 @default.
• W2024247458 hasConcept C188816634 @default.
• W2024247458 hasConcept C2778260677 @default.
• W2024247458 hasConcept C2778292693 @default.
• W2024247458 hasConcept C2778715236 @default.
• W2024247458 hasConcept C2779008522 @default.
• W2024247458 hasConcept C2779134260 @default.

• next